You have 9 free searches left this month | for more free features.

Kirsten rat sarcoma 2 viral oncogene homolog(KRAS)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +14 more
  • ELI-002 7P
  • (no location specified)
Feb 3, 2023

Metastatic Colorectal Cancer (CRC) Trial in Shanghai (BI 1701963, Camptosar®)

Terminated
  • Metastatic Colorectal Cancer (CRC)
  • Shanghai, China
    Shanghai East Hospital, Tongji University China
Apr 19, 2022

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Jan 18, 2023

Infiltrating Urothelial Carcinoma, KRAS Gene Mutation Trial in France (Chemotherapy, Panitumumab)

Completed
  • Infiltrating Urothelial Carcinoma
  • KRAS Gene Mutation
  • Bordeaux, France
  • +16 more
Mar 4, 2021

Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV Trial in Worldwide (Selumetinib, Docetaxel, Placebo)

Active, not recruiting
  • Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
  • Aurora, Colorado
  • +196 more
Dec 22, 2022

Advanced Solid Tumors Trial in Worldwide (BMS-986466, Adagrasib, Cetuximab)

Not yet recruiting
  • Advanced Solid Tumors
  • Birmingham, Alabama
  • +24 more
Aug 29, 2023

Non-Small-Cell Lung Carcinoma, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma Trial (Liquid biopsy)

Not yet recruiting
  • Non-Small-Cell Lung Carcinoma
  • +2 more
  • Liquid biopsy
  • (no location specified)
Jan 24, 2023

Colorectal Cancer, Metastatic Colorectal Cancer Trial in United States (Onvansertib, FOLFIRI, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • Metastatic Colorectal Cancer
  • Birmingham, Alabama
  • +38 more
Jan 25, 2023

Called STAR-T to Learn More About Sequential Treatment With

Not yet recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • Regorafenib (BAY73-4506, Stivarga®)
  • +2 more
  • Whippany, New Jersey
    Many locations
Apr 21, 2023

Colon Cancer, Colorectal Cancer, Rectal Cancer Trial in Worldwide (Panitumumab, Bevacizumab, mFOLFOX6)

Completed
  • Colon Cancer
  • +3 more
  • Birmingham, Alabama
  • +94 more
Nov 10, 2022

KRAS P.G12C Trial in Worldwide (D3S-001)

Recruiting
  • KRAS P.G12C
  • Detroit, Michigan
  • +12 more
Jan 16, 2023

HER3 Expression in Non-Small Cell Lung Cancer

Recruiting
  • Non-small Cell Lung Cancer
  • Archival tissue specimen and immunohistochemistry staining
  • Miami, Florida
  • +1 more
Mar 14, 2023

Advanced Solid Tumors Trial in Worldwide (MK-1084, Pembrolizumab)

Recruiting
  • Advanced Solid Tumors
  • Grand Rapids, Michigan
  • +39 more
Jan 25, 2023

BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Tumor Trial in Houston (biological, drug, other)

Active, not recruiting
  • BRAF NP_004324.2:p.V600X
  • +6 more
  • Cetuximab
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Advanced or Metastatic Solid Tumors Trial (Naporafinib, Trametinib)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • (no location specified)
Jun 21, 2023

Solid Tumor Trial in United States (ASP3082)

Recruiting
  • Solid Tumor
  • Santa Monica, California
  • +10 more
Jan 6, 2023

Recurrent Rectal Cancer, Stage IIA Rectal Cancer, Stage IIB Rectal Cancer Trial in United States (trametinib, fluorouracil,

Active, not recruiting
  • Recurrent Rectal Cancer
  • +6 more
  • Saint Louis, Missouri
  • +3 more
Feb 15, 2022

Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic Trial in Canada, United States (SLC-391, Pembrolizumab)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • +2 more
  • Indianapolis, Indiana
  • +8 more
May 5, 2023

Advanced NSCLC, KRAS Gene Mutation, Lung Cancer Trial in Switzerland (Binimetinib, Pemetrexed, Cisplatin)

Completed
  • Advanced Non-small Cell Lung Cancer
  • +2 more
  • Basel, Switzerland
  • +3 more
Jul 13, 2021

Non Small Cell Lung Cancer Trial in Seoul (sotorasib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jul 5, 2022

Vectibix With Chemotherapy for Metastatic Colorectal Cancer

Completed
  • Wild-type RAS Metastatic Colorectal Cancer
  • Panitumumab + Chemotherapy
  • (no location specified)
Nov 4, 2022

Metastatic Colorectal Cancer Trial in Worldwide (Cetuximab, Panitumumab)

Completed
  • Metastatic Colorectal Cancer
  • Stockton, California
  • +151 more
Sep 8, 2022

Advanced Solid Tumors Trial in Chengdu (GEC255 tablets)

Recruiting
  • Advanced Solid Tumors
  • GEC255 tablets
  • Chengdu, Sichuan, China
    China West Hospital
Mar 14, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Canada (Laboratory Biomarker Analysis, Pharmacological

Completed
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +3 more
  • Calgary, Alberta, Canada
  • +4 more
Feb 10, 2022

Colorectal Cancer, Colorectal Carcinoma, Colorectal Adenocarcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Pexa-Vec)

Active, not recruiting
  • Colorectal Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023